Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600062 stock hub

SHA/600062 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600062is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.5B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600062

In the news

Latest news · SHA/600062

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.6

P25 17.1P50 24.2P75 37.8

Trailing P/E11.4

P25 23.5P50 41.3P75 83.2

ROE13.5

P25 -0.9P50 4.1P75 8.8

ROIC12.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600062 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	13,184
Employees Change	-230%
Employees Change Percent	-1.71
Enterprise value	CNY 18B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000Q94
Last refreshed	2026-05-10
Market cap	CNY 18.5B
Price	CNY 17.94
Price currency	CNY
Rev Per Employee	813,764.22x
Sector	Healthcare
Sic	2834
Symbol	sha/600062
Website	https://www.dcpc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.77%
EV Earnings	11.09x
EV/EBIT	10.74x
EV/EBITDA	7.32x
EV/FCF	24.32x
EV/Sales	1.68x
FCF yield	4%
Forward P/E	10.58x
P/B ratio	1.43x
P/E ratio	11.44x
P/S ratio	1.73x
PE Ratio10 Y	15.63x
PE Ratio3 Y	12.12x
PE Ratio5 Y	13.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.34%
EBITDA Margin	22.42%
FCF margin	6.91%
Gross margin	57.18%
Gross Profit	CNY 6.1B
Gross Profit Growth	-4.26%
Gross Profit Growth Q	-11.09%
Gross Profit Growth3 Y	4.11%
Gross Profit Growth5 Y	2.61%
Net Income	CNY 1.6B
Net Income Growth	0.24%
Net Income Growth Q	-4.3%
Net Income Growth Years	1%
Net Income Growth3 Y	9.94%
Net Income Growth5 Y	9.84%
Pretax Margin	17.3%
Profit Margin	15.15%
Profit Per Employee	CNY 123,266
Profitable Years	32
ROA	5.83
Roa5y	5.8
ROCE	10.97
ROE	13.49
Roe5y	12.57
ROIC	12.86
Roic5y	14.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.13%
Cagr15y	1.86%
Cagr1y	-3.19%
Cagr20y	10.75%
Cagr3y	-1.99%
Cagr5y	11.71%
Div CAGR10	13.87%
Div CAGR3	-15.08%
Div CAGR5	9.15%
EPS Growth	-0.43
EPS Growth Q	-5.13
EPS Growth Years	1
EPS Growth3 Y	9.77
EPS Growth5 Y	9.99
FCF Growth	-32.69%
FCF Growth Q	-67.53%
FCF Growth3 Y	-5.83%
FCF Growth5 Y	-4.95%
OCF Growth	-23.97%
OCF Growth Q	-46.2%
OCF Growth10 Y	5.15%
OCF Growth3 Y	-0.34%
OCF Growth5 Y	0.38%
Revenue Growth	-3.74x
Revenue Growth Q	-8.84x
Revenue Growth Years	0x
Revenue Growth3 Y	2.79x
Revenue Growth5 Y	4.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.61
Assets	CNY 18B
Cash	CNY 3.1B
Current Assets	CNY 8.1B
Current Liabilities	CNY 3B
Debt	CNY 1.7B
Debt EBITDA	CNY 0.7
Debt Equity	CNY 0.13
Debt FCF	CNY 2.28
Equity	CNY 13B
Interest Coverage	49
Liabilities	CNY 5B
Long Term Assets	CNY 10B
Long Term Liabilities	CNY 2B
Net Cash	CNY 1.4B
Net Cash By Market Cap	CNY 7.46
Net Cash Growth	-28.75%
Net Debt EBITDA	CNY -0.57
Net Debt Equity	CNY -0.11
Net Debt FCF	CNY -1.86
Tangible Book Value	CNY 9.2B
Tangible Book Value Per Share	CNY 8.93
WACC	4.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.67
Inventory Turnover	3.07
Net Working Capital	CNY 2.1B
Quick ratio	2.05
Working Capital	CNY 5B
Working Capital Turnover	CNY 2.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.68%
Dividend Growth	31.93%
Dividend Growth Years	2%
Dividend per share	CNY 0.48
Dividend Years	10
Dividend Yield	2.67%
Last Dividend	CNY 0.1
Payout Frequency	Semi-Annual
Payout Ratio	44.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	81.33%
1Y total return	-3.19%
200-day SMA	18.9
3Y total return	-5.86%
50-day SMA	18.23
50-day SMA vs 200-day SMA	50under200
5Y total return	73.96%
All Time High	37.44
All Time High Change	-52.08%
All Time High Date	2022-05-12
All Time Low	1.03
All Time Low Change	1,650.24%
All Time Low Date	1998-08-17
ATR	0.23
Beta	-0
Beta1y	0.04
Beta2y	0.17
Ch YTD	-1.91
High	18.08
High52	22.14
High52 Date	2025-07-31
High52ch	-18.97%
Low	17.9
Low52	17.69
Low52 Date	2026-03-23
Low52ch	1.41%
Ma50ch	-1.61%
Price vs 200-day SMA	-5.1%
RSI	43.62
RSI Monthly	45.77
RSI Weekly	38.67
Sharpe ratio	-0.11x
Sortino ratio	0.19
Total Return	1.99%
Tr YTD	-1.91
Tr15y	31.86%
Tr1m	-2.55%
Tr3m	-3.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.6B
Operating Income Growth	-5.73
Operating Income Growth Q	-4.82
Operating Income Growth3 Y	8.89
Operating Income Growth5 Y	6.7
Operating margin	15.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	400,058,369%
Net Borrowing	459,518,319
Shares Insiders	0.08%
Shares Institutions	9.24%
Shares Out	1,032,802,893
Shares Qo Q	0.05%
Shares Yo Y	0.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 741.5M
Average Volume	8,360,394.2x
Bv Per Share	11.73
CAPEX	CNY -601.6M
Ch10y	50.28
Ch15y	2.23
Ch1m	-2.55
Ch1y	-5.58
Ch20y	463.6
Ch3m	-3.96
Ch3y	-11.45
Ch5y	53.33
Ch6m	-8.14
Change	0.06%
Change From Open	0
Close	17.93
Days Gap	0.06
Depreciation Amortization	760,025,317
Dollar Volume	102,371,201.4
Earnings Date	2026-04-25
EBIT	CNY 1.6B
EBITDA	CNY 2.4B
EPS	CNY 1.57
F Score	4
FCF	CNY 741.5M
FCF EV Yield	4.11x
FCF Per Share	CNY 0.72
Financing CF	-860,277,799
Fiscal Year End	December
Founded	1,939
Goodwill	1,077,015,821
Graham Number	20.34765
Graham Upside	13.42
Income Tax	CNY 193.7M
Investing CF	-1,019,666,516
Is Primary Listing	1
Last Earnings Date	2026-04-25
Last Report Date	2026-03-31
Last Split Date	2018-08-16
Last Split Type	Forward
Lynch Fair Value	CNY 15.43
Lynch Upside	-13.97
Ma150	18.62
Ma150ch	-3.67%
Ma20	18.13
Ma20ch	-1.07%
Net CF	-544,484,030
Next Earnings Date	2026-08-21
Open	17.94
P FCF Ratio	24.99
P OCF Ratio	13.8
Payment Date	2025-10-28
Position In Range	22.22
Ppne	4,553,098,494
Price Date	2026-05-08
Price EBITDA	CNY 7.7
Ptbv Ratio	2.01
Relative Volume	0.67x
Revenue	10,728,667,453x
Tax By Revenue	1.81x
Tax Rate	10.44%
Tr20y	671.27%
Tr6m	-8.14%
Volume	5,706,310

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600062 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.48 annual per share

Payout ratio

+44.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.2%

2 consecutive years of growth

Total shareholder yield

+2.0%

Dividend yield + buyback yield combined

Performance

SHA/600062 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600062?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.2%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

SHA/600062 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

-5.1%

50/200-day relationship not available

Beta (5Y)

-0.00

Less volatile than the market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600062

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600062 stock rating?

sha/600062 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600062 analysis?

The full report lives at /stocks/sha/600062/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600062?

The latest report frames sha/600062 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600062 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.